middle.news
BLS starts FY27 with record revenue and stronger cash generation
8:56am on Wednesday 21st of October, 2026 AEDT
•
Pharmaceuticals
Read Story
BLS starts FY27 with record revenue and stronger cash generation
8:56am on Wednesday 21st of October, 2026 AEDT
Key Points
Record Q1 FY27 revenue of A$26.7 million, up 91% year on year
A$2.0 million in positive net operating cash flow
A$12.7 million cash balance at 30 September 2026
FY27 revenue guidance of A$105 million to A$115 million reaffirmed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bls Pharmaceuticals (ASX:BLS)
OPEN ARTICLE